methoxyhydroxyphenylglycol has been researched along with Depression in 165 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 120 (72.73) | 18.7374 |
1990's | 12 (7.27) | 18.2507 |
2000's | 17 (10.30) | 29.6817 |
2010's | 11 (6.67) | 24.3611 |
2020's | 5 (3.03) | 2.80 |
Authors | Studies |
---|---|
Hakamata, Y; Hanakawa, T; Hori, H; Inoue, Y; Izawa, S; Marusak, H; Mihara, K; Mizukami, S; Moriguchi, Y; Okamura, H; Tagaya, H | 1 |
Igata, R; Ikenouchi, A; Natsuyama, T; Okamoto, N; Yoshimura, R | 1 |
Han, DE; Li, HW; Li, KY; Ma, K; Tian, P; Zhang, W | 1 |
Abaev, K; Becker, M; Ornoy, A; Pinhasov, A; Shmerkin, E; Weinstein-Fudim, L | 1 |
Anderson, AM; Farber, EW; Felger, JC; Franklin, D; Fu, R; Jinnah, H; Letendre, SL; Mckay, JL; Miller, AH; Moore, RC; Sharma, S; Whicker, N | 1 |
Chen, H; Chen, J; Gong, CZ; Huang, XL; Li, MX; Li, Q; Li, RC; Li, Y; Li, YJ; Luo, C; Shi, LP; Sun, XJ; Wang, YN; Xiong, QJ; Zheng, YF | 1 |
Cheng, AW; Dawlaty, MM; Faull, KF; Jaenisch, R; Le, T; Meng, J; Rudenko, A; Seo, J; Tsai, LH | 1 |
Kanno-Nozaki, K; Kunii, Y; Kutsuzawa, Y; Mashiko, H; Miura, I; Niwa, S; Yabe, H | 1 |
Aerts, T; De Deyn, PP; Engelborghs, S; Van Dam, D; Vermeiren, Y | 1 |
Hama, S; Kurisu, K; Murakami, T; Onoda, K; Yamashita, H; Yamawaki, S | 1 |
Battaglia, G; Bruno, V; Caruso, A; Girardi, P; Gruber, SH; Marchiafava, M; Mathè, AA; Matrisciano, F; Melchiorri, D; Nicoletti, F; Orlando, R; Tatarelli, R | 1 |
Isaac, MT | 1 |
Agren, H; Aklillu, E; Karlsson, S; Ozdemir, V; Zachrisson, OO | 1 |
Aklillu, E; Bertilsson, L; Heikkinen, T; Hilli, J; Kishida, I; Laine, K; Lehtimäki, T; Rontu, R; Vahlberg, T | 1 |
Björkqvist, M; Brundin, L; Erhardt, S; Hagell, P; Hansson, O; Janelidze, S; Lindqvist, D; Minthon, L; Samuelsson, M; Träskman-Bendz, L | 1 |
Baroni, S; Brambilla, F; Calugi, S; Dalle Grave, R; Marazziti, D; Marchesini, G | 1 |
Nakamura, K; Nakano, W; Yoshimura, R | 1 |
Berlin, I; Launay, JM; Peoc'h, K; Rendu, F; Thomas, D | 1 |
Fu, S; Li, N; Shi, X; Zhang, L | 1 |
Hamer, M; Harvey, BH; Malan, L; Malan, NT | 1 |
Hayashi, K; Hori, H; Ikenouchi-Sugita, A; Katsuki, A; Nakamura, J; Umene-Nakano, W; Yoshii, C; Yoshimura, R | 1 |
Hamer, M; Malan, L | 1 |
Anderson, GM; Carpenter, LL; Kling, MA; Labiner, DM; Moreno, FA; Price, LH; Regenold, WT | 1 |
Yamada, S | 1 |
Sanada, H; Yoneda, M | 1 |
Goto, M; Kaji, K; Kakihara, S; Nakamura, J; Shinkai, K; Ueda, N; Yamada, Y; Yoshimura, R | 1 |
Burke, AK; Grunebaum, MF; Huang, YY; Mann, JJ; Oquendo, MA; Sher, L | 1 |
Hamer, M; Okamura, H; Steptoe, A; Tanaka, G; Tsuda, A | 1 |
Aoto, H; Kise, M; Mamiya, T; Morikawa, K; Noda, Y; Ukai, M | 1 |
Yoshimura, R | 1 |
Furuse, M; Morimatsu, F; Onitsuka, E; Sato, M; Takahata, Y; Tomonaga, S; Yamada, S; Yamane, H | 1 |
Mayeux, R | 1 |
Asberg, M; Bertilsson, L; Lantto, O; Schalling, D; Träskman, L; Tybring, G | 1 |
Bishop, FM; Goldberg, IJ; Ridges, AP | 1 |
Asberg, M; Bertilsson, L; Oreland, L; Sjöstrand, L; Thorén, P; Träskman, L; Tybring, G; Wiberg, A | 1 |
Krzyzowski, J; Lewicka-Wysocka, H; Lukaszewska, B; Marcjan, K; Pacyna, M; Pietruszewska, I; Roguska, E; Stencka, K | 1 |
Aström, J; Hallert, C; Sedvall, G | 1 |
Abdala, NE; Basombrio, J; Martín, JL; Spatz, H | 1 |
Cote, L; Mayeux, R; Stern, Y; Williams, JB | 1 |
Aguado, EG; de Yebenes, JG; Mena, MA | 1 |
Charney, DS; Heninger, GR; Sternberg, DE | 1 |
Gelenberg, AJ; Gibson, CJ | 1 |
Clayton, PJ; Lewis, CE | 1 |
Emrick, C; Freedman, R; Lubman, A; Mosimann, WF | 1 |
Edwards, DJ; Kupfer, DJ; Neil, JF; Rizk, M; Spiker, DG | 1 |
Birkmayer, W; Riederer, P; Seemann, D; Wuketich, S | 1 |
Anderson, PJ; Barchas, JD; Berger, PA; Davis, KL; Faull, KF; Kilkowski, J; Kraemer, H | 1 |
Beckmann, H; Goodwin, FK | 2 |
Johnson, G | 1 |
Mendels, J; Rush, AJ; Stern, SL | 1 |
Cobbin, D | 1 |
King, D | 1 |
Demet, EM; Halaris, AE | 1 |
Amin, MM; Khalid, R; Khan, P | 1 |
Gaertner, HJ; Kuss, HJ; Wiatr, G | 1 |
Cierpial, MA; Kilts, CD; Scott, PA; Weiss, JM | 1 |
Hashimoto, H; Kai, T; Katayama, M; Koide, S; Onishi, H; Yamagami, S | 1 |
Bennett, B; Hickie, C; Hickie, I; Lloyd, A; Mitchell, P; Silove, D; Wakefield, D | 1 |
Hamanaka, K; Kitayama, I; Nomura, J; Yamashita, K | 1 |
De Brabander, B; Gerits, P; Lamote, J; Sacré, R | 1 |
Haapalinna, A; Kobilka, BK; Lähdesmäki, J; MacDonald, E; Pelto-Huikko, M; Rybnikova, E; Sallinen, J; Scheinin, M; Viitamaa, T | 1 |
George, D; Heinz, A; Hommer, D; Linnoila, M; Weingartner, H; Wolkowitz, OM | 1 |
Bottiglieri, T; Carney, MW; Crellin, R; Laundy, M; Reynolds, EH; Toone, BK | 1 |
Archer, T; Kjellgren, A; Norlander, T; Sundequist, U | 1 |
Breese, GR; Lipton, MA; Prange, AJ; Wilson, IC | 1 |
Asberg, M | 1 |
Asberg, M; Ringberger, VA; Sjöqvist, F; Thorén, P; Träskman, L; Tuck, JR | 1 |
Sharpless, NS | 1 |
Maas, JW | 3 |
Maas, JW; Sweeney, DR | 1 |
Bowers, M; Heninger, G; Maas, J; Nelson, C; Sweeney, D | 1 |
Moussaoui, D | 1 |
Coppen, A; Goodwin, BL; Rama Rao, VA; Ruthven, CR; Sandler, M | 1 |
Gershon, S; Shopsin, B; Wilk, S | 1 |
Black, KE; Buchsbaum, MS; Bunney, WE; Gillin, JC; Post, RM; Runkle, DC; Stoddard, FJ | 1 |
Bunney, WE; Gerner, RH; Gillin, JC; Post, RM | 1 |
Praag, HM | 1 |
Jenner, FA | 1 |
Ridges, AP | 2 |
Davis, JM; Garver, DL | 1 |
Gold, PW; Goodwin, FK; Rebar, R; Wehr, T | 1 |
Garfinkel, PE; Stancer, HC; Warsh, JJ | 1 |
Berger, PA; Slater, P; Yesavage, JA | 1 |
Quitkin, F; Rifkin, A | 1 |
Goodwin, FK; Zis, AP | 1 |
Cobbin, DM; Requin-Blow, B; Williams, LR; Williams, WO | 1 |
Post, RM; Reus, VI; Silberman, E; Weingartner, H | 1 |
Allaria, E; Biondi, PA; Cazzullo, CL; Negri, F; Sacchetti, E; Smeraldi, E | 1 |
Cantwell, DP; Carlson, G | 1 |
Atsmon, A; Blum, I; Davidson, S; Elizur, A; Radwan, M; Steiner, M | 1 |
Beckmann, H; Ebert, MH; Goodwin, FK; Post, R | 1 |
Cytryn, L; McKnew, DH | 1 |
Lecrubier, Y; Puech, AJ; Simon, P | 1 |
Besio, G; Loeb, C; Roccatagliatà, G | 1 |
Anderson, T; Davis, KL; Hollister, LE; Overall, JE | 1 |
Heninger, GR; Kirstein, LS; Maas, JW; Sweeney, DR; Taube, SL | 1 |
Hoppe, E; Nicolaou, N; Rafaelsen, OJ; Sørensen, T; Vestergaard, P; Yates, CM | 1 |
Heninger, GR; Maas, JW; Pickar, D; Sweeney, DR | 1 |
Heninger, GR; Maas, JW; Sweeney, DR | 1 |
Cole, JO; Gudeman, JE; LaBrie, RA; Orsulak, PJ; Rohde, WA; Schatzberg, AF; Schildkraut, JJ | 2 |
Casper, R; Davis, JM; Dekirmenjian, H; Goldberg, S; Halmi, KA | 1 |
Dufour, H | 1 |
Goodwin, FK; Post, RM | 3 |
Davis, JM; Garver, DL; Hengeveld, C; Pandey, GN | 1 |
Baker, M; Brand, E; Goldman, T; Gordon, E; Murphy, DL; van Kammen, D; Wright, C | 1 |
Goodwin, FK; Muscettola, G; Wehr, T | 1 |
Bellodi, L; Biondi, PA; Cagnasso, M; Sacchetti, E; Smeraldi, E | 1 |
Beckmann, H; Goodwin, FK; ST-Laurent, J | 1 |
Dekirmenjian, H; Deleon-Jones, F; Maas, JW; Sanchez, J | 1 |
Dekirmenjian, H; Deleon-Jones, F; Garver, DL; Pandey, GN | 1 |
Goodwin, FK; Gordon, EK; Jimerson, DC; Post, RM | 1 |
Frazier, SH | 1 |
Goodwin, FK; Kotin, J; Post, RM | 1 |
Carreira, I; Casique, M; Lima, L; Morales, M; Silva, C | 1 |
Otero Losada, ME; Rubio, MC | 1 |
Basques, JC; Fabre, ZL; Fernandes, ML; Furtado, CR; Lippi, JR; Lombardi, AB; Peixoto, CC; Queiroz, EA; Soares, TA | 1 |
Gaur, KJ; Johri, MS; Misra, NP; Trivedi, HH | 1 |
Moleman, P | 1 |
Ansseau, M | 1 |
Asberg, M; Wägner, A | 1 |
Alfano, V; Capone, P; Cassano, D; Colucci D'Amato, C; Giordano, E; Marmo, E | 1 |
Alevizos, B; Hatzimanolis, J; Markianos, M; Stefanis, CN | 1 |
Bousquet, B; Dreux, C; Garnier, JP; Lauzel, JP; Manet, L; Tapie, M; Tremine, T | 1 |
Kraus, P; Kuhn, W; Przuntek, H | 1 |
Karoum, F; Linnoila, M; Potter, WZ; Ross, RJ; Rudorfer, MV | 1 |
Alaranta, H; Hurme, M; Hyyppä, MT; Lahtela, K; Scheinin, H; Scheinin, M | 1 |
Benkelfat, C; Dennis, T; Gay, C; Loo, H; Poirier-Littre, MF; Scatton, B | 1 |
Eisenhofer, G; Goldstein, DS; Keiser, HR; Kopin, IJ; Murphy, DL; Stull, R; Sunderland, T | 1 |
DeRubeis, RJ; Evans, M; Garvey, MJ; Hollon, S; Tuason, VB | 1 |
Borg, S; Liljeberg, P; Mossberg, D | 1 |
Benkelfat, C; Deniker, P; Dennis, T; Le Fur, G; Lôo, H; Olié, JP; Poirier, MF; Scätton, B | 1 |
Benkelfat, C; Dennis, T; Loo, H; Olie, JP; Poirier, MF; Scatton, B; Vanelle, JM | 2 |
Askienazy, S; Benkelfat, C; Dennis, T; Gay, C; Lôo, H; Poirier, MF; Scatton, B | 1 |
Iida, H; Myojin, T; Taga, C; Tsuji, M; Yamada, N; Yamane, H | 1 |
McNamee, HB | 1 |
Hartmann, E; Keeler, BA; Papousek, M; Schildkraut, JJ | 1 |
Schildkraut, JJ | 4 |
Beckmann, H; Goodwin, FK; Jones, C | 1 |
Asberg, M; Bertilsson, L; Thorén, P | 1 |
Klein, DF | 1 |
Angrist, B; Gershon, S; Sathananthan, G; Wilk, S | 1 |
Friedman, E; Gershon, S; Goldstein, M; Shopsin, B | 1 |
Kicey, CA | 1 |
Stancer, HC | 1 |
Dekirmenjian, H; Fawcett, JA; Maas, JW | 1 |
Cytryn, L; Desai, RB; Logue, M; McKnew, DH | 1 |
Goodwin, FK; Sack, RL | 1 |
Dekirmenjian, H; Goode, DJ; Maas, JW; Meltzer, HY | 1 |
Brooksbank, BW; Coppen, A; MacSweeney, DA; Noguera, R; O'Keeffe, R; Shaw, DM | 1 |
Hartmann, E; Schildkraut, JJ | 1 |
Davis, K; Gershon, S; Sathananthan, G; Shopsin, B; Wilk, S | 1 |
22 review(s) available for methoxyhydroxyphenylglycol and Depression
Article | Year |
---|---|
Treating depression with SNRIs: who will benefit most?
Topics: Cyclopropanes; Cytochrome P-450 CYP2D6; Depression; Humans; Meta-Analysis as Topic; Methoxyhydroxyphenylglycol; Milnacipran; Pharmacogenetics; Polymorphism, Genetic; Selective Serotonin Reuptake Inhibitors | 2008 |
Smoking related diseases: the central role of monoamine oxidase.
Topics: Anxiety; Biomarkers; Cardiovascular Diseases; Depression; Epigenesis, Genetic; Humans; Hydroxyindoleacetic Acid; Lung Diseases; Methoxyhydroxyphenylglycol; Monoamine Oxidase; Neoplasms; Norepinephrine; Risk Factors; Serotonin; Smoking | 2011 |
[Assessment of mental condition by saliva level of 3-methoxy-4-hydroxyphenylglycol].
Topics: Anxiety Disorders; Biomarkers; Depression; Humans; Methoxyhydroxyphenylglycol; Psychological Tests; Saliva; Stress, Psychological | 2005 |
[3-methoxy-4-hydroxyphenylglycol (MHPG)].
Topics: Alzheimer Disease; Anorexia Nervosa; Biomarkers; Bipolar Disorder; Chromatography, High Pressure Liquid; Depression; Fatigue Syndrome, Chronic; Gas Chromatography-Mass Spectrometry; Humans; Methoxyhydroxyphenylglycol; Norepinephrine; Reference Values; Schizophrenia; Specimen Handling | 2005 |
[Treatment of depression from the point of view of suicide prevention].
Topics: Antidepressive Agents; Biogenic Monoamines; Biomarkers; Brain-Derived Neurotrophic Factor; Depression; Electroconvulsive Therapy; Humans; Methoxyhydroxyphenylglycol; Psychotherapy; Suicide Prevention; Transcranial Magnetic Stimulation | 2007 |
Behavioral manifestations of movement disorders. Parkinson's and Huntington's disease.
Topics: Adult; Aged; Dementia; Depression; Depressive Disorder; Homovanillic Acid; Humans; Huntington Disease; Hydroxyindoleacetic Acid; Intelligence; Methoxyhydroxyphenylglycol; Middle Aged; Parkinson Disease; Personality | 1984 |
Tyrosine for the treatment of depression.
Topics: 5-Hydroxytryptophan; Adult; Animals; Clinical Trials as Topic; Depression; Dihydroxyphenylalanine; Double-Blind Method; Female; Humans; Methoxyhydroxyphenylglycol; Tryptophan; Tyrosine | 1984 |
4-hydroxy-3-methoxyphenylglycol as an index of brain noradrenaline turnover in endogenous depression.
Topics: Aged; Basal Ganglia; Brain; Brain Stem; Depression; Diencephalon; Female; Glycols; Humans; Limbic System; Male; Methoxyhydroxyphenylglycol; Norepinephrine | 1980 |
Behavioral effects of hypothalamic releasing hormones in animals and men.
Topics: Animals; Behavior; Brain; Child; Depression; Female; Gonadotropin-Releasing Hormone; Humans; Hyperkinesis; Methoxyhydroxyphenylglycol; Mice; Motor Activity; MSH Release-Inhibiting Hormone; Norepinephrine; Pentobarbital; Rats; Schizophrenia; Somatostatin; Temperature; Thyrotropin-Releasing Hormone; Tyrosine | 1975 |
Clinical and biochemical heterogeneity of depressive disorders.
Topics: Amitriptyline; Animals; Antidepressive Agents; Brain; Depression; Desipramine; Dextroamphetamine; Emotions; Humans; Imipramine; Metanephrine; Methoxyhydroxyphenylglycol; Neurotransmitter Agents; Norepinephrine; Normetanephrine; Vanilmandelic Acid | 1978 |
Specificity of depressive diseases.
Topics: Brain Chemistry; Depression; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Neurotransmitter Agents; Norepinephrine; Serotonin | 1978 |
Biogenic amine hypotheses of affective disorders.
Topics: Affective Symptoms; Antidepressive Agents; Antidepressive Agents, Tricyclic; Biogenic Amines; Bipolar Disorder; Depression; Electroshock; Humans; Hydroxyindoleacetic Acid; Membranes; Methoxyhydroxyphenylglycol; Monoamine Oxidase Inhibitors; Norepinephrine; Serotonin | 1979 |
Studies of amine metabolites in affective illness and in schizophrenia: a comparative analysis.
Topics: 3,4-Dihydroxyphenylacetic Acid; Antidepressive Agents, Tricyclic; Bipolar Disorder; Brain; Depression; Dopamine; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Mandelic Acids; Methoxyhydroxyphenylglycol; Norepinephrine; Probenecid; Remission, Spontaneous; Schizophrenia; Serotonin; Tranquilizing Agents | 1975 |
Biogenic amines and depression. The potential value of biochemical parameters in the diagnosis and medication of affective disorders.
Topics: Antidepressive Agents; Biogenic Amines; Depression; Diagnosis, Differential; Humans; Hydroxyindoleacetic Acid; Kynurenine; Methoxyhydroxyphenylglycol; Norepinephrine; Normetanephrine; Serotonin; Vanilmandelic Acid | 1976 |
[The importance of methylation reactions in the biochemistry of catecholaminergic and serotoninergic neurons].
Topics: Animals; Brain; Depression; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Methylation; Rats; S-Adenosylmethionine; Serotonin; Sodium | 1991 |
[Biological markers of depression].
Topics: Antidepressive Agents; Apomorphine; Clonidine; Contingent Negative Variation; Depression; Dexamethasone; Diagnosis, Differential; Female; Growth Hormone; Humans; Hydrocortisone; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Pregnancy; Saliva; Sleep, REM | 1986 |
Biochemical effects of antidepressant treatment--studies of monoamine metabolites in cerebrospinal fluid and platelet [3H]imipramine binding.
Topics: Antidepressive Agents; Blood Platelets; Depression; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Imipramine; Methoxyhydroxyphenylglycol; Serotonin | 1986 |
Simulated behavior states: an approach to specificity in psychobiological research.
Topics: Biology; Bipolar Disorder; Cyclic AMP; Depression; Emotions; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Models, Biological; Models, Psychological; Motor Activity; Psychiatry; Research Design; Sleep Deprivation; Stress, Psychological | 1973 |
Biogenic amines and affective disorders.
Topics: Affective Symptoms; Biogenic Amines; Bipolar Disorder; Blood Platelets; Brain; Catechol O-Methyltransferase; Depression; Dopamine; Dopamine beta-Hydroxylase; Electroencephalography; Erythrocytes; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Monoamine Oxidase; Norepinephrine; Serotonin; Sleep, REM | 1974 |
Psychopharmacology. Yesterday, today and tomorrow: a point of view.
Topics: Affective Symptoms; Amitriptyline; Antidepressive Agents; Canada; Carbonates; Depression; Dihydroxyphenylalanine; Drug Industry; Electroconvulsive Therapy; Humans; Imipramine; Lithium; Mental Disorders; Methoxyhydroxyphenylglycol; Monoamine Oxidase Inhibitors; Nicotinic Acids; Psychopharmacology; Research Support as Topic; Schizophrenia; Tranquilizing Agents; Tryptophan; Vitamins | 1973 |
The current status of biological criteria for classifying the depressive disorders and predicting responses to treatment.
Topics: Adult; Aged; Catechol O-Methyltransferase; Depression; Dextroamphetamine; Dihydroxyphenylalanine; Dopamine beta-Hydroxylase; Erythrocytes; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Lithium; Male; Methoxyhydroxyphenylglycol; Middle Aged; Monoamine Oxidase; Sleep; Thyroid Gland | 1974 |
MHPG excretion by patients with affective disorders.
Topics: Affective Symptoms; Bipolar Disorder; Brain; Catecholamines; Creatinine; Depression; Desipramine; Dextroamphetamine; Female; Glycols; Humans; Imipramine; Intellectual Disability; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Normetanephrine; Physical Exertion; Vanilmandelic Acid | 1974 |
16 trial(s) available for methoxyhydroxyphenylglycol and Depression
Article | Year |
---|---|
Effects of cognitive-behavioral therapy on Eating Disorders: neurotransmitter secretory response to treatment.
Topics: Adult; Anxiety; Biogenic Monoamines; Body Mass Index; Cognitive Behavioral Therapy; Depression; Feeding and Eating Disorders; Female; Homovanillic Acid; Humans; Impulsive Behavior; Methoxyhydroxyphenylglycol; Neurotransmitter Agents; Self Concept; Serotonin Plasma Membrane Transport Proteins; Temperament | 2010 |
Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients.
Topics: Adult; Analysis of Variance; Antidepressive Agents; Biogenic Monoamines; Case-Control Studies; Chromatography, High Pressure Liquid; Depression; Electric Stimulation Therapy; Female; gamma-Aminobutyric Acid; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Mass Spectrometry; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Spinal Puncture; Time Factors; Vagus Nerve | 2004 |
Risperidone in the treatment of psychotic depression.
Topics: Adult; Aged; Analysis of Variance; Antidepressive Agents; Antipsychotic Agents; Depression; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Time Factors | 2006 |
Tyrosine for the treatment of depression.
Topics: 5-Hydroxytryptophan; Adult; Animals; Clinical Trials as Topic; Depression; Dihydroxyphenylalanine; Double-Blind Method; Female; Humans; Methoxyhydroxyphenylglycol; Tryptophan; Tyrosine | 1984 |
Effects of bifemelane hydrochloride on plasma neuropeptide Y, 3-methoxy-4-hydroxyphenylethylene glycol and 5-hydroxy-indole acetic acid concentrations in patients with cerebral infarction.
Topics: Aged; Antidepressive Agents; Benzhydryl Compounds; Cerebral Infarction; Chromatography, High Pressure Liquid; Depression; Female; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Neuropeptide Y; Nootropic Agents; Psychiatric Status Rating Scales; Radioimmunoassay | 1995 |
Homocysteine, folate, methylation, and monoamine metabolism in depression.
Topics: Adult; Biogenic Monoamines; Blood Cell Count; Body Weight; Depression; Erythrocytes; Female; Folic Acid; Folic Acid Deficiency; Homocysteine; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Methylation; Middle Aged; S-Adenosylmethionine; Vitamin B 12 | 2000 |
Effects of flotation-REST on muscle tension pain.
Topics: Adult; Anxiety; beta-Endorphin; Chronic Disease; Depression; Female; Headache; Humans; Male; Methoxyhydroxyphenylglycol; Muscle Contraction; Pain; Pain Management; Personality; Psychophysiologic Disorders; Relaxation Therapy; Reproducibility of Results; Sleep | 2001 |
Some of the problems and difficulties associated with clinical studies of antidepressant agents.
Topics: Antidepressive Agents; Clinical Trials as Topic; Depression; Double-Blind Method; Drug Evaluation; Humans; Methoxyhydroxyphenylglycol; Monoamine Oxidase Inhibitors; Placebos; Psychopharmacology; Research | 1977 |
Second-generation antidepressants as research tools--some preliminary findings with clomipramine and maprotiline.
Topics: Adolescent; Adult; Aged; Anthracenes; Clinical Trials as Topic; Clomipramine; Depression; Dibenzazepines; Double-Blind Method; Female; Humans; Hydroxyindoleacetic Acid; Male; Maprotiline; Methoxyhydroxyphenylglycol; Middle Aged; Psychiatric Status Rating Scales | 1977 |
Urinary MHPG: improved tricyclic antidepressant drug selection in clinical practice.
Topics: Antidepressive Agents, Tricyclic; Bipolar Disorder; Circadian Rhythm; Clinical Trials as Topic; Depression; Drug Resistance; Female; Glycols; Humans; Male; Methoxyhydroxyphenylglycol; Prognosis | 1979 |
d-Amphetamine: effects on memory in a depressed population.
Topics: Bipolar Disorder; Depression; Dextroamphetamine; Double-Blind Method; Humans; Memory; Mental Recall; Methoxyhydroxyphenylglycol; Verbal Learning | 1979 |
Antidepressant response to tricyclics and urinary MHPG in unipolar patients. Clinical response to imipramine or amitriptyline.
Topics: Adult; Aged; Amitriptyline; Clinical Trials as Topic; Depression; Female; Glycols; Humans; Imipramine; Male; Methoxyhydroxyphenylglycol; Middle Aged | 1975 |
Urinary 3-methoxy, 4-hydroxyphenylethylene glycol and therapeutic response to maprotiline and indalpine in major depression.
Topics: Adult; Age Factors; Anthracenes; Depression; Female; Glycols; Humans; Male; Maprotiline; Methoxyhydroxyphenylglycol; Middle Aged; Opium; Piperidines; Sex Factors | 1986 |
Differential effect of chlorimipramine and nortriptyline on cerebrospinal fluid metabolites of serotonin and noradrenaline in depression.
Topics: Clomipramine; Depression; Dibenzazepines; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Norepinephrine; Nortriptyline; Placebos; Serotonin | 1974 |
Biochemical correlates of affective disorders in children.
Topics: Acute Disease; Adult; Affective Symptoms; Age Factors; Brain; Child; Chronic Disease; Clinical Trials as Topic; Depression; Female; Glycols; Hospitalization; Humans; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Vanilmandelic Acid | 1974 |
Behavioral effects of a new dopamine-beta-hydroxylase inhibitor (fusaric acid) in man.
Topics: Administration, Oral; Bipolar Disorder; Clinical Trials as Topic; Depression; Dopamine beta-Hydroxylase; Drug Evaluation; Fusaric Acid; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Picolinic Acids | 1974 |
128 other study(ies) available for methoxyhydroxyphenylglycol and Depression
Article | Year |
---|---|
Implicit and explicit emotional memory recall in anxiety and depression: Role of basolateral amygdala and cortisol-norepinephrine interaction.
Topics: Anxiety; Basolateral Nuclear Complex; Depression; Humans; Hydrocortisone; Magnetic Resonance Imaging; Methoxyhydroxyphenylglycol; Norepinephrine | 2022 |
The Molecular Mechanism of Exercise for Treatment of Patients with Major Depression: A Preliminary Report on the Dynamics of Metabolites of Nitric Oxide and Catecholamines.
Topics: Catecholamines; Depression; Depressive Disorder, Major; Homovanillic Acid; Humans; Methoxyhydroxyphenylglycol; Nitric Oxide | 2022 |
[Effect of Rehmanniae Radix on depression-like behavior and hippocampal monoamine neurotransmitters of chronic unpredictable mild stress model rats].
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antidepressive Agents; Chromatography, Liquid; Depression; Disease Models, Animal; Dopamine; Eosine Yellowish-(YS); Hematoxylin; Hippocampus; Homovanillic Acid; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Monoamine Oxidase; Neurotransmitter Agents; Norepinephrine; Plant Extracts; Rats; Rehmannia; Serotonin; Serotonin Plasma Membrane Transport Proteins; Stress, Psychological; Tandem Mass Spectrometry; Tryptophan Hydroxylase | 2022 |
Prenatal SAMe Treatment Induces Changes in Brain Monoamines and in the Expression of Genes Related to Monoamine Metabolism in a Mouse Model of Social Hierarchy and Depression, Probably via an Epigenetic Mechanism.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Monoamines; Brain; Catecholamines; Depression; Dopamine; Epigenesis, Genetic; Female; Hierarchy, Social; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Mice; Norepinephrine; Saline Solution; Serotonin | 2022 |
Cerebrospinal fluid levels of 5-HIAA and dopamine in people with HIV and depression.
Topics: Depression; Dopamine; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Middle Aged; Neurotransmitter Agents; Serotonin | 2023 |
Increased Homer1-mGluR5 mediates chronic stress-induced depressive-like behaviors and glutamatergic dysregulation via activation of PERK-eIF2α.
Topics: Animals; Behavior, Animal; Corticosterone; Depression; Eukaryotic Initiation Factor-2; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Glutamic Acid; Hippocampus; Homer Scaffolding Proteins; Male; Methoxyhydroxyphenylglycol; Mice; Phosphorylation; Pyramidal Cells; Receptor, Metabotropic Glutamate 5; Social Behavior; Stress, Psychological; Synaptic Transmission | 2019 |
Tet1 is critical for neuronal activity-regulated gene expression and memory extinction.
Topics: Age Factors; Analysis of Variance; Animals; Anxiety; Basic Helix-Loop-Helix Transcription Factors; Cerebral Cortex; Conditioning, Classical; Depression; Disease Models, Animal; DNA-Binding Proteins; Exploratory Behavior; Extinction, Psychological; Gene Expression Profiling; Gene Expression Regulation; Hippocampus; In Vitro Techniques; Locomotion; Long-Term Synaptic Depression; Male; Maze Learning; Methoxyhydroxyphenylglycol; Mice; Mice, Inbred C57BL; Mice, Knockout; Nerve Tissue Proteins; Neurons; Oligonucleotide Array Sequence Analysis; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-fos; Receptors, N-Methyl-D-Aspartate; Synapses; Synapsins | 2013 |
High plasma monoamine metabolite levels in Cotard's syndrome.
Topics: Catecholamines; Delusions; Depression; Female; Homovanillic Acid; Humans; Methoxyhydroxyphenylglycol; Middle Aged; Syndrome | 2014 |
Monoaminergic neurotransmitter alterations in postmortem brain regions of depressed and aggressive patients with Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Aggression; Alzheimer Disease; Brain; Chromatography, High Pressure Liquid; Depression; Dopamine; Epinephrine; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Neurotransmitter Agents; Serotonin | 2014 |
Neuroanatomic pathways associated with monoaminergic dysregulation after stroke.
Topics: Adult; Affective Symptoms; Aged; Aged, 80 and over; Apathy; Basal Ganglia; Biogenic Monoamines; Depression; Dopamine; Female; Homovanillic Acid; Humans; Magnetic Resonance Imaging; Male; Methoxyhydroxyphenylglycol; Middle Aged; Multivariate Analysis; Neural Pathways; Norepinephrine; Serotonin; Stroke | 2017 |
Defective group-II metaboropic glutamate receptors in the hippocampus of spontaneously depressed rats.
Topics: Amino Acids; Animals; Antidepressive Agents, Tricyclic; Behavior, Animal; Bridged Bicyclo Compounds, Heterocyclic; Clomipramine; Colforsin; Cyclic AMP; Depression; Disease Models, Animal; Drug Interactions; Gene Expression Regulation; Hippocampus; In Vitro Techniques; Methoxyhydroxyphenylglycol; Rats; Receptors, Metabotropic Glutamate; RNA, Messenger; Swimming | 2008 |
Association of MAOA gene functional promoter polymorphism with CSF dopamine turnover and atypical depression.
Topics: Case-Control Studies; Depression; Dopamine; Female; Genetic Predisposition to Disease; Genetic Variation; Humans; Hydroxyindoleacetic Acid; Logistic Models; Male; Methoxyhydroxyphenylglycol; Models, Biological; Monoamine Oxidase; Polymorphism, Genetic; Promoter Regions, Genetic; Scandinavian and Nordic Countries; Sex Factors; White People | 2009 |
MAO-A and COMT genotypes as possible regulators of perinatal serotonergic symptoms after in utero exposure to SSRIs.
Topics: Catechol O-Methyltransferase; Child; Child, Preschool; Cytochrome P-450 Enzyme System; Depression; Female; Follow-Up Studies; Genetic Predisposition to Disease; Genotype; Humans; Methoxyhydroxyphenylglycol; Monoamine Oxidase; Polymorphism, Genetic; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Prolactin; Prospective Studies; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Serotonin Syndrome; Statistics, Nonparametric | 2009 |
Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity.
Topics: Adult; Analysis of Variance; Blood-Brain Barrier; Cytokines; Depression; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Interleukin-6; Male; Methoxyhydroxyphenylglycol; Middle Aged; Psychiatric Status Rating Scales; Severity of Illness Index; Spinal Puncture; Statistics, Nonparametric; Suicide, Attempted; Young Adult | 2009 |
[Alcoholism and depression: catecholamines and brain-derived neurotrophic factors].
Topics: Adult; Aged; Alcoholism; Antidepressive Agents; Biomarkers; Brain-Derived Neurotrophic Factor; Catecholamines; Cognitive Behavioral Therapy; Depression; Female; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Temperance; Young Adult | 2009 |
Co-involvement of psychological and neurological abnormalities in infertility with polycystic ovarian syndrome.
Topics: 3,4-Dihydroxyphenylacetic Acid; Anxiety; Checklist; Depression; Diagnostic Self Evaluation; Dopamine; Female; Homovanillic Acid; Hostility; Humans; Hydroxyindoleacetic Acid; Infertility, Female; Methoxyhydroxyphenylglycol; Nervous System Diseases; Neurotransmitter Agents; Norepinephrine; Phobic Disorders; Polycystic Ovary Syndrome; Serotonin | 2011 |
Depressive symptoms and sub-clinical atherosclerosis in Africans: role of metabolic syndrome, inflammation and sympathoadrenal function.
Topics: Adult; Analysis of Variance; Atherosclerosis; Black People; Cardiovascular System; Carotid Intima-Media Thickness; Chromatography, High Pressure Liquid; Depression; Electrochemistry; Female; Humans; Inflammation; Male; Metabolic Syndrome; Methoxyhydroxyphenylglycol; Middle Aged; Risk Factors; Tunica Intima; White People | 2011 |
Plasma levels of metabolites of catecholamine in nicotine-dependent patients treated with varenicline.
Topics: Adult; Benzazepines; Catecholamines; Depression; Female; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Disorder; Varenicline | 2012 |
Sympathetic nervous activity, depressive symptoms, and metabolic syndrome in black Africans: the sympathetic activity and ambulatory blood pressure in Africans study.
Topics: Adult; Black People; Blood Pressure; Depression; Female; Humans; Male; Metabolic Syndrome; Methoxyhydroxyphenylglycol; Middle Aged; Risk Factors; Stress, Psychological; Sympathetic Nervous System | 2012 |
CSF monoamine metabolites and lethality of suicide attempts in depressed patients with alcohol dependence.
Topics: Adult; Alcoholism; Biogenic Monoamines; Depression; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Suicide, Attempted | 2007 |
The effects of depressive symptoms on cardiovascular and catecholamine responses to the induction of depressive mood.
Topics: Adult; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Catecholamines; Depression; Female; Heart Rate; Humans; Male; Methoxyhydroxyphenylglycol; Saliva; Stress, Psychological; Surveys and Questionnaires; Sympathetic Nervous System; Verbal Behavior | 2007 |
Effects of pre-germinated brown rice on depression-like behavior in mice.
Topics: Animals; Behavior, Animal; Blotting, Western; Brain Chemistry; Depression; Diet; Helplessness, Learned; Hippocampus; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Mice; Mice, Inbred ICR; Motor Activity; Neostriatum; Norepinephrine; Oryza; Pain Measurement; Prefrontal Cortex; Receptor, Serotonin, 5-HT1A; Serotonin; Serotonin Plasma Membrane Transport Proteins; Swimming | 2007 |
Carnosine-induced antidepressant-like activity in rats.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Biogenic Monoamines; Carnosine; Chickens; Depression; Hippocampus; Hypothalamus; Male; Methoxyhydroxyphenylglycol; Motor Activity; Norepinephrine; Rats; Rats, Wistar | 2008 |
Cortisol in the CSF of depressed and suicidal patients.
Topics: Adjustment Disorders; Clomipramine; Depression; Female; Homovanillic Acid; Humans; Hydrocortisone; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Suicide, Attempted | 1980 |
Urinary amine metabolites in depression: a combined biochemical and general practice study: II. Biochemical aspects.
Topics: Adolescent; Adult; Aged; Biogenic Amines; Clomipramine; Depression; Family Practice; Female; Humans; Hydroxyindoleacetic Acid; Male; Maprotiline; Methoxyhydroxyphenylglycol; Middle Aged; Psychiatric Status Rating Scales; Time Factors | 1980 |
Platelet MAO activity and monoamine metabolites in cerebrospinal fluid in depressed and suicidal patients and in healthy controls.
Topics: Blood Platelets; Depression; Female; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Monoamine Oxidase; Phenylacetates; Suicide, Attempted | 1981 |
[Metabolism of peripheral catecholamines and indole amines in healthy persons. Clinico-biochemical correlates].
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Carboxylic Acids; Catecholamines; Depression; Female; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Phenylacetates; Vanilmandelic Acid | 1981 |
Psychic disturbances in adult coeliac disease. III. Reduced central monoamine metabolism and signs of depression.
Topics: Adult; Aged; Biogenic Amines; Celiac Disease; Depression; Dopamine; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Middle Aged; MMPI; Norepinephrine; Serotonin | 1982 |
[Clinical, biochemical and psychopharmacologic correlates in patients with depressive symptomatology].
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Depression; Female; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Phenethylamines; Phenylacetates; Serotonin | 1980 |
Altered serotonin metabolism in depressed patients with parkinson's disease.
Topics: Aged; Depression; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Parkinson Disease; Serotonin | 1984 |
Monoamine metabolites in human cerebrospinal fluid. HPLC/ED method.
Topics: 3,4-Dihydroxyphenylacetic Acid; Alzheimer Disease; Chromatography, High Pressure Liquid; Depression; Dihydroxyphenylalanine; Electrochemistry; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Parkinson Disease; Phenylacetates; Subarachnoid Hemorrhage; Tryptophan; Tyrosine | 1984 |
Assessment of alpha 2 adrenergic autoreceptor function in humans: effects of oral yohimbine.
Topics: Adult; Analysis of Variance; Antidepressive Agents; Anxiety; Blood Pressure; Clonidine; Depression; Drug Therapy, Combination; Female; Heart Rate; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Receptors, Adrenergic; Receptors, Adrenergic, alpha; Yohimbine | 1982 |
The significance of secondary depression.
Topics: Adult; Age Factors; Depression; Female; Humans; Male; Mental Disorders; Methoxyhydroxyphenylglycol; Middle Aged; Sex Factors; Sleep, REM; Socioeconomic Factors | 1981 |
Altered mood and norepinephrine metabolism following withdrawal from alcohol.
Topics: Alcoholism; Creatinine; Depression; Emotions; Female; Humans; Male; Methoxyhydroxyphenylglycol; MMPI; Norepinephrine; Psychiatric Status Rating Scales; Substance Withdrawal Syndrome | 1983 |
The new psychiatry.
Topics: Depression; Dexamethasone; Humans; Hydrocortisone; Methoxyhydroxyphenylglycol | 1981 |
MHPG excretion in depression.
Topics: Adult; Amitriptyline; Bipolar Disorder; Depression; Female; Glycols; Humans; Male; Methoxyhydroxyphenylglycol; Psychiatric Status Rating Scales; Recurrence | 1980 |
CSF monoamine metabolites in depression and schizophrenia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Depression; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Probenecid; Schizophrenia | 1980 |
Urinary MHPG in subgroups of depressed patients and normal controls.
Topics: Adult; Age Factors; Aged; Anxiety; Bipolar Disorder; Blood Pressure; Depression; Diastole; Female; Glycols; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Schizophrenia; Sex Factors; Systole | 1980 |
Urinary MHPG in depression: a cautionary note.
Topics: Antidepressive Agents, Tricyclic; Depression; Glycols; Humans; Methoxyhydroxyphenylglycol | 1980 |
Toward a rational pharmacotherapy of depression.
Topics: Antidepressive Agents, Tricyclic; Bipolar Disorder; Depression; Dextroamphetamine; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Lithium; Methoxyhydroxyphenylglycol; Monoamine Oxidase Inhibitors | 1980 |
Urinary MHPG in depression.
Topics: Antidepressive Agents, Tricyclic; Depression; Glycols; Humans; Methoxyhydroxyphenylglycol | 1980 |
Sleep deprivation therapy in depression syndromes.
Topics: Blood Pressure; Circadian Rhythm; Depression; Humans; Hydrocortisone; Methoxyhydroxyphenylglycol; Monoamine Oxidase; Sleep Deprivation; Sleep, REM | 1980 |
Open trial evaluation of a pyrrolidine derivative (AHR-1118) on norepinephrine metabolism.
Topics: Antidepressive Agents; Depression; Humans; Methoxyhydroxyphenylglycol; Norepinephrine; Psychiatric Status Rating Scales; Pyrrolidines; Time Factors | 1980 |
Relationship between sleep deprivation and urinary MHPG levels.
Topics: Adult; Depression; Female; Glycols; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Sleep Deprivation | 1980 |
4-methoxy-3-hydroxyphenylglycol as an internal standard for the determination of 3-methoxy-4-hydroxyphenyglycol in urine: results obtained in depressed patients and healthy controls.
Topics: Chromatography, Gas; Depression; Evaluation Studies as Topic; Glycols; Humans; Methoxyhydroxyphenylglycol; Reference Values | 1980 |
Susceptibility and resistance of rats to stress-induced decreases in swim-test activity: a selective breeding study.
Topics: Animals; Breeding; Catecholamines; Depression; Disease Susceptibility; Female; Hypothalamus; Locus Coeruleus; Male; Methoxyhydroxyphenylglycol; Neurons; Norepinephrine; Rats; Rats, Sprague-Dawley; Selection, Genetic; Stress, Physiological; Swimming; Tyrosine 3-Monooxygenase | 1996 |
Biochemical correlates of in vivo cell-mediated immune dysfunction in patients with depression: a preliminary report.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Depression; Epinephrine; Female; Humans; Hydrocortisone; Hypersensitivity, Delayed; Immunity, Cellular; Longitudinal Studies; Male; Methoxyhydroxyphenylglycol; Middle Aged | 1995 |
Effect of reserpine on 3-methoxy-4-hydroxyphenylethyleneglycol and 3,4-dihydroxyphenylacetic acid in the hippocampus of depression-model rats: an in vivo microdialysis study.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Depression; Female; Hippocampus; Kinetics; Methoxyhydroxyphenylglycol; Microdialysis; Motor Activity; Physical Exertion; Rats; Rats, Wistar; Reserpine; Stress, Psychological; Walking | 1998 |
What determines primary breast cancer patients' hope to recover.
Topics: Adaptation, Psychological; Adult; Aged; Arousal; Breast Neoplasms; Depression; Female; Humans; Internal-External Control; Interview, Psychological; Methoxyhydroxyphenylglycol; Middle Aged; Motivation; Norepinephrine; Prognosis; Sick Role | 1998 |
Genetic alteration of the alpha2-adrenoceptor subtype c in mice affects the development of behavioral despair and stress-induced increases in plasma corticosterone levels.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Cerebral Cortex; Corpus Striatum; Corticosterone; Depression; Dopamine; Genes, Immediate-Early; Genetic Markers; Hippocampus; Homovanillic Acid; Hydroxyindoleacetic Acid; In Situ Hybridization; Methoxyhydroxyphenylglycol; Mice; Mice, Transgenic; Norepinephrine; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Receptors, Adrenergic, alpha-2; Restraint, Physical; RNA, Messenger; Serotonin; Stress, Physiological; Swimming | 1999 |
Severity of depression in abstinent alcoholics is associated with monoamine metabolites and dehydroepiandrosterone-sulfate concentrations.
Topics: Adult; Case-Control Studies; Dehydroepiandrosterone; Depression; Ethanol; Female; Homovanillic Acid; Humans; Hydrocortisone; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Neurotransmitter Agents; Psychiatric Status Rating Scales; Severity of Illness Index; Statistics, Nonparametric; Substance Withdrawal Syndrome | 1999 |
Treatment of depression with tricyclic drugs--pharmacokinetic and pharmacodynamic aspects.
Topics: Antidepressive Agents, Tricyclic; Clomipramine; Depression; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Neurons; Neurotransmitter Agents; Norepinephrine; Nortriptyline; Serotonin; Suicide; Tyramine | 1976 |
Monoamine metabolites in cerebrospinal fluid and serotonin uptake inhibition during treatment with chlorimipramine.
Topics: Biogenic Amines; Clomipramine; Depression; Depression, Chemical; Dibenzazepines; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Neurotransmitter Agents; Norepinephrine; Serotonin; Time Factors | 1977 |
Determination of 3-methoxy-4-hydroxyphenylglycol in urine and the effect of diet on its excretion.
Topics: Chromatography, Gas; Depression; Diet; Female; Glycols; Humans; Hydrogen-Ion Concentration; Hydrolysis; Male; Methoxyhydroxyphenylglycol | 1977 |
Delusional versus non-delusional depression: Neurochemical differences.
Topics: Adult; Delusions; Depression; Drug Resistance; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Middle Aged | 1978 |
Biochemical classification of depression.
Topics: Brain; Catecholamines; Depression; Humans; Kidney; Methoxyhydroxyphenylglycol | 1979 |
[Respective position of antidepressants in therapeutics (author's transl)].
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Catechol O-Methyltransferase; Depression; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Monoamine Oxidase | 1979 |
Urinary 4-hydroxy-3-methoxyphenylglycol is not a predictor for clinical response to amitriptyline in depressive illness.
Topics: Amitriptyline; Depression; Female; Glycols; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Sex Factors | 1979 |
Exploration of affective illness.
Topics: Adult; Bipolar Disorder; Brain; Depression; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fenclonine; Humans; Imipramine; Male; Methoxyhydroxyphenylglycol; Methyltyrosines; Middle Aged; Serotonin | 1976 |
Alterations in motor activity, sleep, and biochemistry in a cycling manic-depressive patient.
Topics: Adult; Behavior; Bipolar Disorder; Depression; Electrophysiology; Emotions; Eye Movements; Female; Humans; Longitudinal Studies; Methoxyhydroxyphenylglycol; Motor Activity; Norepinephrine; Psychiatric Status Rating Scales; Self-Assessment; Sleep; Sleep, REM | 1977 |
Biological and behavioral effects of one night's sleep deprivation in depressed patients and normals.
Topics: Adult; Aged; Bipolar Disorder; Body Temperature; Calcium; Circadian Rhythm; Depression; Electroencephalography; Emotions; Glycols; Homovanillic Acid; Humans; Hydrocortisone; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Middle Aged; Phenylacetates; Sleep Deprivation; Sleep, REM | 1979 |
Biochemistry of the affective disorders.
Topics: Affective Symptoms; Bipolar Disorder; Body Temperature; Cholinesterase Inhibitors; Circadian Rhythm; Depression; Dopamine; Homovanillic Acid; Humans; Methoxyhydroxyphenylglycol; Monoamine Oxidase Inhibitors; Norepinephrine; Sleep, REM | 1979 |
The Harold E. Himwich Memorial Lecture. Significance of biochemical parameters in the diagnosis, treatment, and prevention of depressive disorders.
Topics: 5-Hydroxytryptophan; Antidepressive Agents, Tricyclic; Autopsy; Bipolar Disorder; Brain Chemistry; Central Nervous System; Depression; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Monoamine Oxidase Inhibitors; Norepinephrine; Serotonin; Serotonin Antagonists; Vanilmandelic Acid | 1977 |
Pituitary thyrotropin response to thyrotropin-releasing hormone in affective illness: relationship to spinal fluid amine metabolites.
Topics: Age Factors; Bipolar Disorder; Depression; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Menstruation; Methoxyhydroxyphenylglycol; Sex Factors; Thyrotropin; Thyrotropin-Releasing Hormone | 1977 |
Depression: new evidence in support of biological differentiation.
Topics: Adult; Bipolar Disorder; Carbidopa; Depression; Female; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Tryptamines; Tryptophan | 1979 |
Repertory grid and biochemical characterization of depression: a comparison of case reports.
Topics: 3,4-Dihydroxyphenylacetic Acid; Depression; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Interpersonal Relations; Male; Methoxyhydroxyphenylglycol; Middle Aged; Nortriptyline; Personality; Psychological Tests; Psychotherapy; Social Perception | 1979 |
MHPG excretion.
Topics: Depression; Glycols; Humans; Methoxyhydroxyphenylglycol | 1979 |
Novel antidepressants and the biogenic amine hypothesis of depression. The case for iprindole and mianserin.
Topics: Adjustment Disorders; Affective Disorders, Psychotic; Amitriptyline; Biogenic Amines; Brain; Depression; Dibenzazepines; Dose-Response Relationship, Drug; Humans; Imipramine; Indoles; Iprindole; Methoxyhydroxyphenylglycol; Mianserin; Norepinephrine; Serotonin | 1979 |
Urinary MHPG levels and tricyclic antidepressant drug selection. A preliminary communication on improved drug selection in clinical practice.
Topics: Adult; Antidepressive Agents, Tricyclic; Bipolar Disorder; Depression; Glycols; Humans; Methoxyhydroxyphenylglycol; Psychiatric Status Rating Scales | 1979 |
3-Methoxy-4-hydroxyphenylglycol and primary depression: clinical and pharmacological considerations.
Topics: Adult; Aged; Amitriptyline; Bipolar Disorder; Clomipramine; Depression; Female; Glycols; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged | 1979 |
Problems and prospects in the study of childhood depression.
Topics: Adjustment Disorders; Antidepressive Agents; Bipolar Disorder; Child; Depression; Follow-Up Studies; Humans; Methoxyhydroxyphenylglycol; Methyltransferases; Monoamine Oxidase | 1979 |
Urinary 3-methoxy-4-hydroxyphenylglycol (MHPG) excretion in depression.
Topics: Adult; Bipolar Disorder; Depression; Electroconvulsive Therapy; Female; Glycols; Humans; Imipramine; Male; Methoxyhydroxyphenylglycol; Middle Aged | 1979 |
Effect of moderate exercise on urinary MHPG in depressed patients.
Topics: Depression; Epinephrine; Glycols; Humans; Methoxyhydroxyphenylglycol; Norepinephrine; Physical Exertion; Time Factors | 1979 |
Urinary metabolites in chronically depressed children.
Topics: Child; Chronic Disease; Depression; Female; Humans; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Vanilmandelic Acid | 1979 |
[The role of norepinephrine in affective disorders (author's transl)].
Topics: Antidepressive Agents; Bipolar Disorder; Depression; Humans; Methoxyhydroxyphenylglycol; Norepinephrine; Receptors, Adrenergic | 1979 |
[Variations in the urinary level of MHPG in depressive syndromes].
Topics: Adult; Age Factors; Aged; Antidepressive Agents, Tricyclic; Anxiety; Depression; Depressive Disorder; Depressive Disorder, Major; Female; Glycols; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Monoamine Oxidase Inhibitors; Perphenazine; Recurrence; Trazodone; Viloxazine | 1979 |
Excretion of MHPG in normal subjects: implications for biological classification of affective disorders.
Topics: Adolescent; Adult; Affective Symptoms; Circadian Rhythm; Creatinine; Depression; Emotions; Female; Glycols; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Physical Exertion; Sex Factors | 1978 |
Urinary 3-methoxy-4-hydroxyphenylglycol and psychiatric diagnosis.
Topics: Adult; Depression; Diagnosis, Differential; Female; Glycols; Humans; Methoxyhydroxyphenylglycol; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1978 |
Biogenic amine metabolites in cerebrospinal fluid of patients with affective disorders.
Topics: Adult; Aged; Biogenic Amines; Bipolar Disorder; Depression; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged | 1978 |
Primary affective disorder, clinical state change, and MHPG excretion: a longitudinal study.
Topics: Adult; Bipolar Disorder; Depression; Female; Follow-Up Studies; Glycols; Humans; Methoxyhydroxyphenylglycol; Middle Aged | 1978 |
State anxiety, physical activity, and urinary 3-methoxy-4-hydroxyphenethylene glycol excretion.
Topics: Adult; Anxiety; Bipolar Disorder; Depression; Female; Glycols; Humans; Methoxyhydroxyphenylglycol; Middle Aged; Physical Exertion; Schizophrenia | 1978 |
Toward a biochemical classification of depressive disorders. I. Differences in urinary excretion of MHPG and other catecholamine metabolites in clinically defined subtypes of depressions.
Topics: Adult; Bipolar Disorder; Depression; Epinephrine; Female; Glycols; Humans; Male; Metanephrine; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Normetanephrine; Schizophrenia; Vanilmandelic Acid | 1978 |
Toward a biochemical classification of depressive disorders. II. Application of multivariate discriminant function analysis to data on urinary catecholamines and metabolites.
Topics: Adult; Bipolar Disorder; Depression; Epinephrine; Factor Analysis, Statistical; Female; Glycols; Humans; Male; Metanephrine; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Normetanephrine; Schizophrenia; Vanilmandelic Acid | 1978 |
Catecholamine metabolism in anorexia nervosa.
Topics: Adolescent; Adult; Anorexia Nervosa; Blood Pressure; Body Weight; Child; Creatinine; Cyproheptadine; Depression; Female; Glycols; Humans; Metanephrine; Methoxyhydroxyphenylglycol; MMPI; Normetanephrine; Psychiatric Status Rating Scales; Pulse | 1978 |
[Depressive inhibition].
Topics: Affective Symptoms; Behavior; Depression; Humans; Inhibition, Psychological; Intelligence; Methoxyhydroxyphenylglycol; Motor Activity; Norepinephrine | 1978 |
Growth hormone response and central aminergic systems in affective diseases [proceedins].
Topics: Affective Symptoms; Apomorphine; Biogenic Amines; Bipolar Disorder; Depression; Growth Hormone; Humans; Hypoglycemia; Methoxyhydroxyphenylglycol | 1977 |
Platelet and plasma amine oxidase inhibition and urinary amine excretion changes during phenelzine treatment.
Topics: Blood Platelets; Catecholamines; Depression; Enzyme Repression; Epinephrine; Humans; Mandelic Acids; Metanephrine; Methoxyhydroxyphenylglycol; Monoamine Oxidase; Norepinephrine; Normetanephrine; Phenelzine; Plasma; Serotonin; Time Factors; Tryptamines | 1977 |
Effect of diet on urinary MHPG excretion in depressed patients and normal control subjects.
Topics: Adolescent; Adult; Anxiety; Bipolar Disorder; Catecholamines; Depression; Diet; Emotions; Female; Glycols; Humans; Male; Methoxyhydroxyphenylglycol; Time Factors | 1977 |
MHPG, amitriptyline and affective disorders. A longitudinal study.
Topics: Adult; Affective Symptoms; Amitriptyline; Depression; Glycols; Humans; Longitudinal Studies; Male; Methoxyhydroxyphenylglycol; Time Factors | 1976 |
The effect of lithium on urinary MHPG in unipolar and bipolar depressed patients.
Topics: Adult; Bipolar Disorder; Depression; Female; Glycols; Humans; Lithium; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Psychiatric Status Rating Scales; Time Factors | 1975 |
Diagnostic subgroups of affective disorders and their urinary excretion of catecholamine metabolities.
Topics: Bipolar Disorder; Catecholamines; Depression; Female; Humans; Metanephrine; Methoxyhydroxyphenylglycol; Normetanephrine; Vanilmandelic Acid | 1975 |
Growth hormone catecholamines in affective disease.
Topics: Adult; Bipolar Disorder; Blood Glucose; Depression; Depression, Chemical; Female; Glycols; Growth Hormone; Humans; Hypoglycemia; Insulin; Male; Methoxyhydroxyphenylglycol; Middle Aged | 1975 |
Central noradrenergic function in man: vanillylmandelic acid in CSF.
Topics: Acute Disease; Affective Symptoms; Bipolar Disorder; Depression; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Mental Disorders; Methoxyhydroxyphenylglycol; Schizophrenia; Vanilmandelic Acid | 1975 |
Biogenic amines and depression. Biochemical and pharmacological separation of two types of depression.
Topics: Amitriptyline; Biogenic Amines; Depression; Desipramine; Dextroamphetamine; Humans; Hydroxyindoleacetic Acid; Imipramine; Metanephrine; Methoxyhydroxyphenylglycol; Normetanephrine; Nortriptyline; Vanilmandelic Acid | 1975 |
Changing patterns in the management of depression.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Depression; Humans; Lithium; Methoxyhydroxyphenylglycol; Monoamine Oxidase Inhibitors | 1976 |
Effects of sleep deprivation on mood and central amine metabolism in depressed patients.
Topics: Adult; Affect; Aged; Brain; Depression; Dopamine; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Serotonin; Sleep Deprivation | 1976 |
[Treatment of patients with panic disorder and an elevated urinary excretion of MHPG using imipramine or clonazepam].
Topics: Adult; Anxiety Disorders; Clonazepam; Depression; Female; Humans; Imipramine; Lactates; Lactic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Panic Disorder; Paranoid Disorders; Prevalence; Psychological Tests; Schizophrenia | 1992 |
Biochemical correlate of depression in children.
Topics: Adolescent; Age Factors; Analysis of Variance; Catecholamines; Child; Child, Abandoned; Depression; Female; Homovanillic Acid; Humans; Hydrocortisone; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Psychiatric Status Rating Scales; Sex Factors | 1991 |
Value of DOPEG estimation in CSF in depression.
Topics: Depression; Female; Humans; India; Male; Methoxyhydroxyphenylglycol; Norepinephrine | 1990 |
Effect of diet on urinary excretion of unconjugated catecholamines and some of their metabolites in healthy control subjects and depressed patients.
Topics: Adult; Aged; Biogenic Monoamines; Catecholamines; Creatinine; Depression; Diet; Female; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged | 1990 |
[A multidisciplinary approach to the diagnostic problem of headache].
Topics: Depression; Headache; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Personality | 1987 |
Effect of moclobemide on clinical and neurochemical variables in depressed patients (preliminary findings).
Topics: Adult; Benzamides; Blood Platelets; Depression; Female; Growth Hormone; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Prolactin; Thyrotropin | 1988 |
[Determination of 3-methoxy-4-hydroxyphenyethylene-glycol and its urinary conjugates. Value in the diagnosis and therapeutic follow-up of depression].
Topics: Clomipramine; Depression; Drug Therapy, Combination; Follow-Up Studies; Glycols; Humans; Hydroxyindoleacetic Acid; Methoxyhydroxyphenylglycol; Mianserin; Psychiatric Status Rating Scales; Vanilmandelic Acid | 1988 |
The effect of R-(-)-deprenyl in de novo parkinsonian patients pretreated with levodopa and decarboxylase inhibitor correlated to depression and MHPG, HIAA and HVA levels in the cerebrospinal fluid.
Topics: Benserazide; Depression; Double-Blind Method; Drug Therapy, Combination; Female; Glycols; Homovanillic Acid; Humans; Hydrazines; Hydroxyindoleacetic Acid; Levodopa; Male; Methoxyhydroxyphenylglycol; Middle Aged; Motor Activity; Parkinson Disease; Phenethylamines; Selegiline | 1989 |
Differences in lithium effects in depressed and healthy subjects.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Depression; Dopamine; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Lithium; Male; Methoxyhydroxyphenylglycol; Neurotransmitter Agents; Norepinephrine; Serotonin | 1985 |
Neurotransmission and the experience of low back pain; no association between CSF monoamine metabolites and pain.
Topics: Adult; Anxiety; Back Pain; Depression; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Neurotransmitter Agents | 1985 |
Decrease in plasma levels of 3,4-dihydroxyphenylethyleneglycol in major depression.
Topics: Adolescent; Adult; Age Factors; Aged; Bipolar Disorder; Depression; Depressive Disorder; Female; Glycols; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Psychiatric Status Rating Scales; Sex Factors | 1986 |
Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase.
Topics: Alzheimer Disease; Animals; Catecholamines; Chromatography, Liquid; Depression; Dihydroxyphenylalanine; Dogs; Glycols; Humans; Methoxyhydroxyphenylglycol; Monoamine Oxidase Inhibitors; Posture; Quality Control; Selegiline; Tranylcypromine | 1986 |
The association of MHPG to dexamethasone suppression test status.
Topics: Adult; Depression; Dexamethasone; Female; Glycols; Humans; Hydrocortisone; Male; Methoxyhydroxyphenylglycol | 1988 |
Clinical conditions and central noradrenergic activity in long term abstinent alcoholic patients.
Topics: Affect; Alcoholism; Cognition; Depression; Glycols; Humans; Male; Methoxyhydroxyphenylglycol | 1987 |
[Cerebral noradrenaline metabolism and classification of depression].
Topics: Blood Platelets; Brain; Depression; Humans; Methoxyhydroxyphenylglycol; Monoamine Oxidase; Norepinephrine | 1986 |
Plasma 3,4-dihydroxyphenylethyleneglycol levels in depressed patients with and without abnormal dexamethasone suppression.
Topics: Adult; Age Factors; Aged; Depression; Dexamethasone; Female; Glycols; Humans; Hydrocortisone; Male; Methoxyhydroxyphenylglycol; Middle Aged | 1986 |
Plasma 3,4-dihydroxyphenylethyleneglycol and therapeutic response to maprotiline and indalpine in major depression.
Topics: Adult; Aged; Anthracenes; Depression; Female; Glycols; Humans; Male; Maprotiline; Methoxyhydroxyphenylglycol; Middle Aged; Piperidines | 1986 |
Studies on 3-methoxy-4-hydroxyphenylglycol (MHPG) and 3,4-dihydroxyphenylglycol (DHPG) levels in human urine, plasma and cerebrospinal fluids, and their significance in studies of depression.
Topics: Adult; Chromatography, High Pressure Liquid; Depression; Glycols; Humans; Maprotiline; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine | 1986 |
Letter: Tryptophan in depression.
Topics: Depression; Humans; Methoxyhydroxyphenylglycol; Tryptophan | 1974 |
MHPG excretion in depressive disorders: relation to clinical subtypes and desynchronized sleep.
Topics: Adolescent; Adult; Age Factors; Aged; Bipolar Disorder; Depression; Female; Glycols; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Sleep, REM | 1973 |
[Different urinary excretion of 3-methoxy-4-hydroxyphenyl-glycol and response to tricyclic antidepressive drugs].
Topics: Amitriptyline; Depression; Female; Glycols; Humans; Imipramine; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Serotonin | 1974 |
Proceedings: Pharmacological response as a basis for syndrome identification.
Topics: Adjustment Disorders; Affective Symptoms; Antidepressive Agents; Depression; Humans; Methoxyhydroxyphenylglycol | 1974 |
Proceedings: Norepinephrine metabolism in subtypes of depressive disorders.
Topics: Antidepressive Agents; Catecholamines; Depression; Humans; Methoxyhydroxyphenylglycol; Norepinephrine | 1974 |
Proceedings: Cerebrospinal fluid MHPG in affective disorders: state dependent vs. state independent variables.
Topics: Affective Symptoms; Antidepressive Agents; Depression; Glycols; Humans; Methoxyhydroxyphenylglycol | 1974 |
Amphetamine psychosis: behavioral and biochemical aspects.
Topics: Adolescent; Adult; Affect; Alcoholism; Amphetamine; Brain; Cognition Disorders; Delusions; Depression; Dextroamphetamine; Dihydroxyphenylalanine; Dopamine; Dose-Response Relationship, Drug; Ethylene Glycols; Hallucinations; Haloperidol; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Psychoses, Substance-Induced; Receptors, Drug; Schizophrenia; Schizophrenic Language; Schizophrenic Psychology; Stereoisomerism | 1974 |
Proceedings: Drugs, mood, and amines: a profile in psychobiological research.
Topics: Animals; Antidepressive Agents; Biogenic Amines; Depression; Emotions; Humans; Imipramine; Methoxyhydroxyphenylglycol; Methyltyrosines; Rats | 1974 |
Catecholamines and depression: a physiological theory of depression.
Topics: Brain; Depression; Dihydroxyphenylalanine; Humans; Methoxyhydroxyphenylglycol; Monoamine Oxidase Inhibitors; Norepinephrine; Vanilmandelic Acid | 1974 |
Norepinephrine metabolites as biochemical criteria for classifying depressive disorders and predicting responses to treatment: preliminary findings.
Topics: Adolescent; Adult; Aged; Amitriptyline; Depression; Female; Glycols; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Normetanephrine; Probability; Vanilmandelic Acid | 1973 |
Relation of exercise to MHPG excretion in normal subjects.
Topics: Adolescent; Adult; Analysis of Variance; Depression; Fatigue; Glycols; Humans; Methods; Methoxyhydroxyphenylglycol; Motor Activity; Norepinephrine; Normetanephrine; Physical Exertion; Rest; Stress, Physiological | 1973 |
3-Methoxy-4-hydroxyphenylglycol in depression.
Topics: Brain; Depression; Female; Glycols; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Personality Assessment; Psychiatric Status Rating Scales | 1973 |
Desynchronized sleep and MHPG excretion: an inverse correlation.
Topics: Affective Symptoms; Age Factors; Brain; Cortical Synchronization; Depression; Electroencephalography; Glycols; Humans; Methoxyhydroxyphenylglycol; Norepinephrine; Sleep; Sleep Stages | 1973 |
Catecholamines and affective disorders revised: a critical assessment.
Topics: Affective Symptoms; Animals; Bipolar Disorder; Brain; Catecholamines; Depression; Dopamine beta-Hydroxylase; Female; Humans; Male; Methoxyhydroxyphenylglycol; Nervous System Diseases; Norepinephrine; Rats; Tritium; Tyrosine | 1974 |